US Bancorp’s abrdn Life Sciences Investors HQL Stock Holding History

US Bancorp’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-75	Closed	-$1K	–	3582
2016 Q4	$1K	Hold	75	–	–	﹤0.01%	3449
2016 Q3	$1K	Buy	+75	New	+$1.41K	﹤0.01%	3450
2016 Q2	–	Sell	-1,741	Closed	-$31K	–	3582
2016 Q1	$31K	Hold	1,741	–	–	﹤0.01%	2594
2015 Q4	$41K	Buy	1,741 +69	+4%	+$1.71K	﹤0.01%	2531
2015 Q3	$38K	Buy	+1,672	New	+$46.8K	﹤0.01%	2592
2014 Q2	–	Sell	-4,315	Closed	-$94K	–	3516
2014 Q1	$94K	Hold	4,315	–	–	﹤0.01%	2146
2013 Q4	$88K	Hold	4,315	–	–	﹤0.01%	2175
2013 Q3	$83K	Hold	4,315	–	–	﹤0.01%	2112
2013 Q2	$77K	Buy	+4,315	New	+$77.9K	﹤0.01%	2126

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

US Bancorp's HQL Position: Q1 2017 in Review

US Bancorp sold out of abrdn Life Sciences Investors (HQL) in Q1 2017, closing a stake of 75 shares — an estimated $1K sold.

US Bancorp first reported a position in HQL in Q2 2013 and held it in 9 quarters. The position peaked at $94K in Q1 2014. 41 funds tracked by Wall St. Rank hold HQL as of Q1 2017.

US Bancorp reported no remaining abrdn Life Sciences Investors position as of Q1 2017 after selling out during the quarter.
US Bancorp sold 75 abrdn Life Sciences Investors shares in Q1 2017, an estimated $1K.
US Bancorp first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 9 quarters.
US Bancorp's abrdn Life Sciences Investors position peaked at $94K in Q1 2014.
41 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2017.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.